Daniel A. Solomon

879 total citations
30 papers, 393 citations indexed

About

Daniel A. Solomon is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Daniel A. Solomon has authored 30 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Infectious Diseases. Recurrent topics in Daniel A. Solomon's work include Opioid Use Disorder Treatment (9 papers), HIV, Drug Use, Sexual Risk (8 papers) and Antibiotic Use and Resistance (5 papers). Daniel A. Solomon is often cited by papers focused on Opioid Use Disorder Treatment (9 papers), HIV, Drug Use, Sexual Risk (8 papers) and Antibiotic Use and Resistance (5 papers). Daniel A. Solomon collaborates with scholars based in United States, Brazil and Saudi Arabia. Daniel A. Solomon's co-authors include Amy C Sherman, Sanjat Kanjilal, Paul E. Sax, Joji Suzuki, Mary W. Montgomery, Jennifer A. Johnson, Christin N. Price, Jessica S Little, Lindsey R. Baden and Krista G. Freeman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Daniel A. Solomon

26 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Solomon United States 9 196 154 93 78 38 30 393
K Alshafi United Kingdom 9 139 0.7× 192 1.2× 35 0.4× 68 0.9× 55 1.4× 12 422
Diego Torrús Spain 14 226 1.2× 94 0.6× 309 3.3× 57 0.7× 15 0.4× 46 554
M. Cafferkey Ireland 12 330 1.7× 191 1.2× 50 0.5× 16 0.2× 54 1.4× 20 564
Frieder Pfäfflin Germany 9 90 0.5× 112 0.7× 30 0.3× 16 0.2× 50 1.3× 28 307
Eric M. Poolman United States 10 180 0.9× 184 1.2× 48 0.5× 28 0.4× 11 0.3× 10 385
Daniel Gebretsadik Ethiopia 12 135 0.7× 112 0.7× 112 1.2× 25 0.3× 7 0.2× 44 400
José A. Bazan United States 13 269 1.4× 128 0.8× 73 0.8× 11 0.1× 50 1.3× 44 587
Jean Ronald Edoa Gabon 10 88 0.4× 68 0.4× 84 0.9× 44 0.6× 26 0.7× 33 295
Patrick Danaher United States 13 193 1.0× 152 1.0× 40 0.4× 12 0.2× 45 1.2× 42 508
Lucille Blumberg South Africa 12 266 1.4× 273 1.8× 70 0.8× 43 0.6× 24 0.6× 18 444

Countries citing papers authored by Daniel A. Solomon

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Solomon more than expected).

Fields of papers citing papers by Daniel A. Solomon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Solomon. The network helps show where Daniel A. Solomon may publish in the future.

Co-authorship network of co-authors of Daniel A. Solomon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Solomon. A scholar is included among the top collaborators of Daniel A. Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Solomon. Daniel A. Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chuan-Chin, et al.. (2025). Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018–2023. Open Forum Infectious Diseases. 12(6). ofaf312–ofaf312.
2.
Paras, Molly L, et al.. (2024). Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open Forum Infectious Diseases. 11(4). ofae186–ofae186. 9 indexed citations
3.
Solomon, Daniel A. & Paul E. Sax. (2024). Advances in the Management of HIV. Infectious Disease Clinics of North America. 38(3). i–i.
6.
Solomon, Daniel A., et al.. (2023). Perspectives on the Use of Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs: Results From an Online Survey of Infectious Diseases Clinicians. Open Forum Infectious Diseases. 10(7). ofad372–ofad372. 2 indexed citations
7.
Solomon, Daniel A., et al.. (2023). 757. Bridging the Gap: An Educational Intervention to Increase HIV PrEP Access in Resident Primary Care Clinics. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
8.
Thakarar, Kinna, Monica K Sikka, Daniel A. Solomon, et al.. (2023). ‘I feel like they’re actually listening to me’: a pilot study of a hospital discharge decision-making conversation guide for patients with injection drug use–associated infections. Therapeutic Advances in Infectious Disease. 10. 2018399924–2018399924. 6 indexed citations
9.
Little, Jessica S, Rebekah M. Dedrick, Krista G. Freeman, et al.. (2022). Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection. Nature Communications. 13(1). 2313–2313. 90 indexed citations
11.
Sikka, Monica K, Daniel A. Solomon, Ellen Eaton, et al.. (2022). Health care professional perspectives on discharging hospitalized patients with injection drug use-associated infections. Therapeutic Advances in Infectious Disease. 9. 2008361684–2008361684. 9 indexed citations
12.
Solomon, Daniel A.. (2020). Seasonal Influenza Vaccination. JAMA. 324(13). 1362–1362. 6 indexed citations
13.
Suzuki, Joji, Jennifer A. Johnson, Mary W. Montgomery, et al.. (2019). Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. Journal of Addiction Medicine. 14(4). 282–286. 23 indexed citations
14.
Bourque, Daniel, Daniel A. Solomon, & Paul E. Sax. (2019). Health Considerations for HIV-Infected International Travelers. Current Infectious Disease Reports. 21(5). 16–16. 3 indexed citations
15.
Solomon, Daniel A.. (2019). HIV Initial Assessment and Routine Follow-up. Infectious Disease Clinics of North America. 33(3). 647–662.
16.
Beckman, Joshua A., Brian R. Wood, Kevin L. Ard, et al.. (2017). Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir. PLoS ONE. 12(10). e0181993–e0181993. 8 indexed citations
17.
Solomon, Daniel A. & Paul E. Sax. (2015). Current state and limitations of daily oral therapy for treatment. Current Opinion in HIV and AIDS. 10(4). 219–225. 28 indexed citations
18.
Solomon, Daniel A. & Danny A. Milner. (2014). ID Learning Unit: Understanding and Interpreting Testing for Clostridium difficile. Open Forum Infectious Diseases. 1(1). ofu007–ofu007. 8 indexed citations
19.
Solomon, Daniel A., Christopher H. Fanta, Bruce D. Levy, & Joseph Loscalzo. (2012). Whistling in the Dark. New England Journal of Medicine. 366(18). 1725–1730. 2 indexed citations
20.
Solomon, Daniel A., et al.. (2010). Accepting a donor kidney: an evaluation of patients’ and transplant surgeons’ priorities. Clinical Transplantation. 25(5). 786–793. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026